Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvelestat in Bronchiectasis
NCT00769119Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of alvelestat in bronchiectasis, sponsored by AstraZeneca. Started Sep 2008; status: completed.
02
Drugs
alvelestat
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT00769119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769119.